4 Einträge gefunden

1. ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer

   1. Grote, Isabel
   2. Bartels, Stephan
   3. Christgen, Henriette
   4. Radner, Martin
   5. Gronewold, Malte
   6. Kandt, Leonie
   7. Raap, Mieke

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer

   1. Nitz, Ulrike A
   2. Gluz, Oleg
   3. Kümmel, Sherko
   4. Christgen, Matthias
   5. Braun, Michael
   6. Aktas, Bahriye
   7. Lüdtke-Heckenkamp, Kerstin

   2022 - Forschungsinformationssystem des UKE
3. De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial

   1. Nitz, Ulrike
   2. Gluz, Oleg
   3. Graeser, Monika
   4. Christgen, Matthias
   5. Kuemmel, Sherko
   6. Grischke, Eva-Maria
   7. Braun, Michael

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial

   1. Gluz, Oleg
   2. Nitz, Ulrike
   3. Kolberg-Liedtke, Cornelia
   4. Prat, Aleix
   5. Christgen, Matthias
   6. Kuemmel, Sherko
   7. Mohammadian, Mohammad Parsa

   2022 - Forschungsinformationssystem des UKE